Ticagrelor Tablets IP (IP indicates Indian Pharmacopoeia) is a medication that belongs to the class of antiplatelet drugs. Ticagrelor is the active pharmaceutical ingredient (API) in these tablets. It is used to prevent blood clots from forming and blocking blood vessels, particularly in individuals with acute coronary syndrome (ACS), including unstable angina or myocardial infarction (heart attack).
Ticagrelor works by inhibiting the aggregation or clumping together of platelets, which are small blood cells involved in the formation of blood clots. By preventing platelet aggregation, it reduces the risk of thrombotic events such as heart attacks or strokes.
The tablets come in various strengths, typically ranging from 60 mg to 90 mg. The specific strength and dosage regimen depend on the patient’s condition and the prescribing physician’s instructions.
To use Ticagrelor Tablets IP:
Here are some potential benefits of Ticagrelor tablets IP:
Prevention of heart attack and stroke: It works by preventing platelets from sticking together and forming blood clots, which can block blood vessels supplying the heart or brain.
Reduced cardiovascular events: Ticagrelor has been shown to decrease the occurrence of major adverse cardiac events, including heart attack, stroke, and cardiovascular death, in patients with ACS compared to other antiplatelet medications.
Increased blood flow: By inhibiting platelet aggregation, Ticagrelor promotes better blood flow through narrowed or blocked arteries. This improved circulation can help alleviate symptoms such as chest pain (angina) and reduce the risk of complications.
Rapid onset of action: Ticagrelor has a faster onset of action compared to some other antiplatelet medications. It quickly begins to inhibit platelet function and prevent clot formation, providing more immediate protection against cardiovascular events.
Reversible effect: Unlike some other antiplatelet agents, Ticagrelor’s effects are reversible. This means that if a patient requires urgent surgery or experiences excessive bleeding, the drug’s effects can be reversed more quickly, allowing for necessary medical interventions.
Long-term use: Ticagrelor can be prescribed for long-term use in patients who require ongoing prevention of blood clots. This provides sustained protection against cardiovascular events in individuals at high risks, such as those with a history of heart attack or stroke.
Common side effects of Ticagrelor tablets IP include:
Here are some precautions to be aware of when taking Ticagrelor Tablets IP:
Ticagrelor Tablets IP